Evidence map›Paper›PMID 41755782›Full record

ArticleBiomolecules & therapeutics2026

Celafolin A-1 Ameliorates Subretinal Fibrosis via Inhibition of Crystallin Alpha B in a Laser-Induced Choroidal Neovascularization Mouse Model.

Eunhye Yu, Sun Mi Gu, Haechan Kim, Jun Gu Kim, Bang Yeon Hwang, Jung Kee Min, Jaesuk Yun

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomolecules & therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Eunhye YuCollege of Pharmacy, Chungbuk National University, Cheongju 28160, Republic of Korea.
Sun Mi GuCollege of Pharmacy, Chungbuk National University, Cheongju 28160, Republic of Korea.
Haechan KimCollege of Pharmacy, Chungbuk National University, Cheongju 28160, Republic of Korea.
Jun Gu KimCollege of Pharmacy, Chungbuk National University, Cheongju 28160, Republic of Korea.
Bang Yeon HwangCollege of Pharmacy, Chungbuk National University, Cheongju 28160, Republic of Korea.
Jung Kee MinDepartment of Ophthalmology, Ulsan University Hospital, University of Ulsan, College of Medicine, Ulsan 44033, Republic of Korea.
Jaesuk YunCollege of Pharmacy, Chungbuk National University, Cheongju 28160, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Age-related macular degeneration (AMD) is a leading cause of blindness in people over 65 years old. Anti-vascular endothelial growth factor (VEGF) therapy is the first-line treatment for neovascular AMD (nAMD); however, fibrosis remains an unmet medical need due to the lack of effective medications. This study evaluated eight natural products from

Indexed as

Biolayer interferometry assayChoroidal neovascularizationCrystallin alpha BNatural productsNeovascular age-related macular degeneration

Identifiers

PMID41755782
PMCPMC12961977

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.